Clinical Trial

TAR-0520 Gel in EGFR Inhibitor-induced Folliculitis

Name: TAR-0520 Gel in EGFR Inhibitor-induced Folliculitis — clinical trial record (NCT06818058)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

A Phase II, multicentric, randomized, double-blind, placebo-controlled, parallel- group trial to confirm the good safaty profile and to explore the preventive effect of topically applied TAR-0520 gel on folliculitis developed in metastatic colorectal cancer (mCRC) patients treated with monoclonal anti-EGFR antibodies.

Trial Details

NCT Number	NCT06818058
Lead Sponsor	Tarian Pharma
Conditions	EGFR Inhibitor-associated Rash
Enrollment	60 participants
Start Date	2025-01-20
Primary Completion	2026-09-01 (estimated)
Study Completion	2026-09-30 (estimated)
Updated on ClinicalTrials.gov	2025-02-10